PMC:7161517 / 21603-21763 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T65","span":{"begin":27,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"uberon_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T266","span":{"begin":27,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A266","pred":"chebi_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T136","span":{"begin":0,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T24590","span":{"begin":57,"end":64},"obj":"PR:000009054"},{"id":"T6576","span":{"begin":105,"end":136},"obj":"PG_10;PR:000003622"},{"id":"T15507","span":{"begin":138,"end":142},"obj":"G_3;PG_10;PR:000003622"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"933","span":{"begin":9,"end":15},"obj":"Chemical"},{"id":"943","span":{"begin":136,"end":140},"obj":"Disease"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}

{"project":"2_test","denotations":[{"id":"32305401-28877748-55252978","span":{"begin":156,"end":158},"obj":"28877748"}],"text":"Although rhACE2 attenuated RAS mediators, infusions of the medication did not show improvement in physiological or clinical measures of ARDs in this study (57)."}